GlassScriptPhysician profile
David L Tharpe
NPI 1902864440
$1,772.79
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $400 · 2020: $183 · 2021: $249 · 2022: $289 · 2023: $637 · 2024: $15.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $652.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $553.22 | 2019-2024 | Lokelma, Farxiga |
| Vifor Pharma, INC. | $206.18 | 2019-2023 | Veltassa |
| Akebia Therapeutics INC | $193.82 | 2019-2022 | |
| Fresenius USA Marketing, INC. | $98.48 | 2021-2023 | Velphoro, Korsuva |
| Travere Therapeutics, INC. | $93.52 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $90.70 | 2022-2023 | |
| Mallinckrodt Hospital Products INC. | $76.63 | 2020-2021 | |
| Opko Pharmaceuticals, LLC | $74.81 | 2019-2020 | |
| Glaxosmithkline, LLC. | $71.55 | 2022-2023 | Benlysta |
| Otsuka America Pharmaceutical, INC. | $71.10 | 2021-2023 | Jynarque |
| Horizon Therapeutics Plc | $55.86 | 2023 | Krystexxa |
| Aurinia Pharma U.S., INC. | $43.81 | 2023 | Lupkynis |
| Calliditas Therapeutics US INC. | $35.42 | 2023 | Tarpeyo |
| Mallinckrodt Enterprises LLC | $32.97 | 2019 | |
| Amgen INC. | $22.76 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $20.89 | 2021 | |
| Ani Pharmaceuticals, INC. | $16.71 | 2022 | |
| Alexion Pharmaceuticals, INC. | $14.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Tharpe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.